-
1
-
-
40849085072
-
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
-
McKinnon PS, Paladino JA, Schentag JJ (2008) Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents 31:345-351
-
(2008)
Int J Antimicrob Agents
, vol.31
, pp. 345-351
-
-
McKinnon, P.S.1
Paladino, J.A.2
Schentag, J.J.3
-
2
-
-
84875273480
-
Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia
-
Muller AE, Punt N, Mouton JW (2013) Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia. J Antimicrob Chemother 68:900-906
-
(2013)
J Antimicrob Chemother
, vol.68
, pp. 900-906
-
-
Muller, A.E.1
Punt, N.2
Mouton, J.W.3
-
3
-
-
34248328649
-
Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections
-
DOI 10.1128/AAC.00294-06
-
Li C, Du X, Kuti JL, Nicolau DP (2007) Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections. Antimicrob Agents Chemother 51:1725-1730 (Pubitemid 46744151)
-
(2007)
Antimicrobial Agents and Chemotherapy
, vol.51
, Issue.5
, pp. 1725-1730
-
-
Li, C.1
Du, X.2
Kuti, J.L.3
Nicolau, D.P.4
-
4
-
-
84884211532
-
Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues
-
Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H (2013) Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues. Intensive Care Med 39:345-364
-
(2013)
Intensive Care Med
, vol.39
, pp. 345-364
-
-
Antonelli, M.1
Bonten, M.2
Cecconi, M.3
Chastre, J.4
Citerio, G.5
Conti, G.6
Curtis, J.R.7
Hedenstierna, G.8
Joannidis, M.9
Macrae, D.10
Maggiore, S.M.11
Mancebo, J.12
Mebazaa, A.13
Preiser, J.C.14
Rocco, P.15
Timsit, J.F.16
Wernerman, J.17
Zhang, H.18
-
5
-
-
84863807810
-
Subtherapeutic initial beta-lactam concentrations in select critically ill patients: Association between augmented renal clearance and low trough drug concentrations
-
Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney BC, Ungerer JP, Lipman J, Roberts JA (2012) Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 142:30-39
-
(2012)
Chest
, vol.142
, pp. 30-39
-
-
Udy, A.A.1
Varghese, J.M.2
Altukroni, M.3
Briscoe, S.4
McWhinney, B.C.5
Ungerer, J.P.6
Lipman, J.7
Roberts, J.A.8
-
6
-
-
77954738622
-
Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: Special emphasis on unbound pharmacokinetics
-
Ulldemolins M, Roberts JA, Wallis SC, Rello J, Lipman J (2010) Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics. J Antimicrob Chemother 65:1771-1778
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 1771-1778
-
-
Ulldemolins, M.1
Roberts, J.A.2
Wallis, S.C.3
Rello, J.4
Lipman, J.5
-
7
-
-
15944400991
-
Antibiotic rotation and development of Gram-negative antibiotic resistance
-
DOI 10.1164/rccm.200401-070OC
-
van Loon HJ, Vriens MR, Fluit AC, Troelstra A, van der Werken C, Verhoef J, Bonten MJM (2005) Antibiotic rotation and development of gramnegative antibiotic resistance. Am J Respir Crit Care Med 171:480-487 (Pubitemid 40444248)
-
(2005)
American Journal of Respiratory and Critical Care Medicine
, vol.171
, Issue.5
, pp. 480-487
-
-
Van Loon, H.J.1
Vriens, M.R.2
Fluit, A.C.3
Troelstra, A.4
Van Der, W.C.5
Verhoef, J.6
Bonten, M.J.M.7
-
8
-
-
84886248419
-
Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients
-
Carlier M, Noe M, De Waele JJ, Stove V, Verstraete AG, Lipman J, Roberts JA (2013) Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients. J Antimicrob Chemother 68:2600-2608
-
(2013)
J Antimicrob Chemother
, vol.68
, pp. 2600-2608
-
-
Carlier, M.1
Noe, M.2
De Waele, J.J.3
Stove, V.4
Verstraete, A.G.5
Lipman, J.6
Roberts, J.A.7
-
9
-
-
84877003713
-
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: Does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
-
Carlier M, Carrette S, Roberts JA, Stove V, Verstraete AG, Hoste E, Decruyenaere J, Depuydt P, Lipman J, Wallis SC, De Waele JJ (2013) Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? Crit Care 17:R84
-
(2013)
Crit Care
, vol.17
-
-
Carlier, M.1
Carrette, S.2
Roberts, J.A.3
Stove, V.4
Verstraete, A.G.5
Hoste, E.6
Decruyenaere, J.7
Depuydt, P.8
Lipman, J.9
Wallis, S.C.10
De Waele, J.J.11
-
10
-
-
84921947756
-
Year in review in Intensive Care Medicine 2013: Iii. Sepsis, infections, respiratory diseases, pediatrics
-
Timsit JF, Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Azoulay E (2014) Year in review in Intensive Care Medicine 2013: iii. sepsis, infections, respiratory diseases, pediatrics. Intensive Care Med 40:471-483
-
(2014)
Intensive Care Med
, vol.40
, pp. 471-483
-
-
Timsit, J.F.1
Citerio, G.2
Bakker, J.3
Bassetti, M.4
Benoit, D.5
Cecconi, M.6
Curtis, J.R.7
Hernandez, G.8
Herridge, M.9
Jaber, S.10
Joannidis, M.11
Papazian, L.12
Peters, M.13
Singer, P.14
Smith, M.15
Soares, M.16
Torres, A.17
Vieillard-Baron, A.18
Azoulay, E.19
-
11
-
-
84876410012
-
Identifying patients at risk for augmented renal clearance in the ICU - limitations and challenges
-
Carlier M, De Waele JJ (2013) Identifying patients at risk for augmented renal clearance in the ICU - limitations and challenges. Crit Care 17:130
-
(2013)
Crit Care
, vol.17
, pp. 130
-
-
Carlier, M.1
De Waele, J.J.2
-
12
-
-
84872871549
-
Case-control study of drug monitoring of beta-lactams in obese critically ill patients
-
Hites M, Taccone FS, Wolff F, Cotton F, Beumier M, De Backer D, Roisin S, Lorent S, Surin R, Seyler L, Vincent JL, Jacobs F (2013) Case-control study of drug monitoring of beta-lactams in obese critically ill patients. Antimicrob Agents Chemother 57:708-715
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 708-715
-
-
Hites, M.1
Taccone, F.S.2
Wolff, F.3
Cotton, F.4
Beumier, M.5
De Backer, D.6
Roisin, S.7
Lorent, S.8
Surin, R.9
Seyler, L.10
Vincent, J.L.11
Jacobs, F.12
-
13
-
-
84897414453
-
DALI: Defining antibiotic levels in intensive care unit patients: Are current beta-lactam antibiotic doses sufficient for critically ill patients?
-
Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J (2014) DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072-1083
-
(2014)
Clin Infect Dis
, vol.58
, pp. 1072-1083
-
-
Roberts, J.A.1
Paul, S.K.2
Akova, M.3
Bassetti, M.4
De Waele, J.J.5
Dimopoulos, G.6
Kaukonen, K.M.7
Koulenti, D.8
Martin, C.9
Montravers, P.10
Rello, J.11
Rhodes, A.12
Starr, T.13
Wallis, S.C.14
Lipman, J.15
-
14
-
-
84863431581
-
DALI: Defining antibiotic levels in intensive care unit patients: A multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic
-
Roberts JA, De Waele JJ, Dimopoulos G, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J (2012) DALI: defining antibiotic levels in intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic. BMC Infect Dis 12:152
-
(2012)
BMC Infect Dis
, vol.12
, pp. 152
-
-
Roberts, J.A.1
De Waele, J.J.2
Dimopoulos, G.3
Koulenti, D.4
Martin, C.5
Montravers, P.6
Rello, J.7
Rhodes, A.8
Starr, T.9
Wallis, S.C.10
Lipman, J.11
-
15
-
-
0022256529
-
APACHE II: A severity of disease classification system
-
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-829 (Pubitemid 15250137)
-
(1985)
Critical Care Medicine
, vol.13
, Issue.10
, pp. 818-829
-
-
Knaus, W.A.1
Draper, E.A.2
Wagner, D.P.3
Zimmerman, J.E.4
-
16
-
-
0030015661
-
The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine
-
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710
-
(1996)
Intensive Care Med
, vol.22
, pp. 707-710
-
-
Vincent, J.L.1
Moreno, R.2
Takala, J.3
Willatts, S.4
De Mendonca, A.5
Bruining, H.6
Reinhart, C.K.7
Suter, P.M.8
Thijs, L.G.9
-
17
-
-
84855393537
-
Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story
-
Lipman J, Udy AA, Roberts JA (2011) Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story. Anaesth Intensive Care 39:999-1000
-
(2011)
Anaesth Intensive Care
, vol.39
, pp. 999-1000
-
-
Lipman, J.1
Udy, A.A.2
Roberts, J.A.3
-
18
-
-
84888203416
-
Clinical implications of antibiotic pharmacokinetic principles in the critically ill
-
Udy AA, Roberts JA, Lipman J (2013) Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Med 39:2070-2082
-
(2013)
Intensive Care Med
, vol.39
, pp. 2070-2082
-
-
Udy, A.A.1
Roberts, J.A.2
Lipman, J.3
-
19
-
-
33846442436
-
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: Clinical implications of an extended-infusion dosing strategy
-
DOI 10.1086/510590
-
Lodise TP Jr, Lomaestro B, Drusano GL (2007) Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis 44:357-363 (Pubitemid 46147617)
-
(2007)
Clinical Infectious Diseases
, vol.44
, Issue.3
, pp. 357-363
-
-
Lodise Jr., T.P.1
Lomaestro, B.2
Drusano, G.L.3
-
20
-
-
70249113663
-
Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients
-
Shea KM, Cheatham SC, Wack MF, Smith DW, Sowinski KM, Kays MB (2009) Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients. Int J Antimicrob Agents 34:429-433
-
(2009)
Int J Antimicrob Agents
, vol.34
, pp. 429-433
-
-
Shea, K.M.1
Cheatham, S.C.2
Wack, M.F.3
Smith, D.W.4
Sowinski, K.M.5
Kays, M.B.6
-
21
-
-
79953811686
-
Optimization of meropenem dosage in the critically ill population based on renal function
-
Crandon JL, Ariano RE, Zelenitsky SA, Nicasio AM, Kuti JL, Nicolau DP (2011) Optimization of meropenem dosage in the critically ill population based on renal function. Intensive Care Med 37:632-638
-
(2011)
Intensive Care Med
, vol.37
, pp. 632-638
-
-
Crandon, J.L.1
Ariano, R.E.2
Zelenitsky, S.A.3
Nicasio, A.M.4
Kuti, J.L.5
Nicolau, D.P.6
-
22
-
-
84871758823
-
Continuous infusion of beta-lactam antibiotics in severe sepsis: A multicenter double-blind, randomized controlled trial
-
Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Lipman J (2013) Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis 56:236-244
-
(2013)
Clin Infect Dis
, vol.56
, pp. 236-244
-
-
Dulhunty, J.M.1
Roberts, J.A.2
Davis, J.S.3
Webb, S.A.4
Bellomo, R.5
Gomersall, C.6
Shirwadkar, C.7
Eastwood, G.M.8
Myburgh, J.9
Paterson, D.L.10
Lipman, J.11
-
23
-
-
28144459346
-
Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: A systematic review of pharmacokinetic and pharmacodynamic parameters
-
DOI 10.2165/00003495-200565170-00006
-
Kasiakou SK, Lawrence KR, Choulis N, Falagas ME (2005) Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: a systematic review of pharmacokinetic and pharmacodynamic parameters. Drugs 65:2499-2511 (Pubitemid 41697317)
-
(2005)
Drugs
, vol.65
, Issue.17
, pp. 2499-2511
-
-
Kasiakou, S.K.1
Lawrence, K.R.2
Choulis, N.3
Falagas, M.E.4
-
24
-
-
34249866197
-
Continuous infusion of beta-lactam antibiotics in severe infections: A review of its role
-
DOI 10.1016/j.ijantimicag.2007.02.002, PII S0924857907000908
-
Roberts JA, Paratz J, Paratz E, Krueger WA, Lipman J (2007) Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. Int J Antimicrob Agents 30:11-18 (Pubitemid 46874893)
-
(2007)
International Journal of Antimicrobial Agents
, vol.30
, Issue.1
, pp. 11-18
-
-
Roberts, J.A.1
Paratz, J.2
Paratz, E.3
Krueger, W.A.4
Lipman, J.5
-
25
-
-
79959337263
-
Does prolonged beta-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials
-
Tamma PD, Putcha N, Suh YD, Van Arendonk KJ, Rinke ML (2011) Does prolonged beta-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials. BMC Infect Dis 11:181
-
(2011)
BMC Infect Dis
, vol.11
, pp. 181
-
-
Tamma, P.D.1
Putcha, N.2
Suh, Y.D.3
Van Arendonk, K.J.4
Rinke, M.L.5
-
26
-
-
84864766676
-
Augmented renal clearance in the critically ill: How to assess kidney function
-
Grootaert V, Willems L, Debaveye Y, Meyfroidt G, Spriet I (2012) Augmented renal clearance in the critically ill: how to assess kidney function. Ann Pharmacother 46:952-959
-
(2012)
Ann Pharmacother
, vol.46
, pp. 952-959
-
-
Grootaert, V.1
Willems, L.2
Debaveye, Y.3
Meyfroidt, G.4
Spriet, I.5
-
27
-
-
84894437155
-
Augmented renal clearance in the ICU: Results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations
-
Udy AA, Baptista JP, Lim NL, Joynt GM, Jarrett P, Wockner L, Boots RJ, Lipman J (2014) Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations. Crit Care Med 42:520-527
-
(2014)
Crit Care Med
, vol.42
, pp. 520-527
-
-
Udy, A.A.1
Baptista, J.P.2
Lim, N.L.3
Joynt, G.M.4
Jarrett, P.5
Wockner, L.6
Boots, R.J.7
Lipman, J.8
-
28
-
-
78650304326
-
Augmented creatinine clearance in traumatic brain injury
-
Udy A, Boots R, Senthuran S, Stuart J, Deans R, Lassig-Smith M, Lipman J (2010) Augmented creatinine clearance in traumatic brain injury. Anesth Analg 111:1505-1510
-
(2010)
Anesth Analg
, vol.111
, pp. 1505-1510
-
-
Udy, A.1
Boots, R.2
Senthuran, S.3
Stuart, J.4
Deans, R.5
Lassig-Smith, M.6
Lipman, J.7
-
30
-
-
84874380062
-
Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: Identifying at-risk patients
-
Udy AA, Roberts JA, Shorr AF, Boots RJ, Lipman J (2013) Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients. Crit Care 17:R35
-
(2013)
Crit Care
, vol.17
-
-
Udy, A.A.1
Roberts, J.A.2
Shorr, A.F.3
Boots, R.J.4
Lipman, J.5
-
31
-
-
84863278700
-
Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: A structured review
-
Adnan S, Paterson DL, Lipman J, Kumar S, Li J, Rudd M, Roberts JA (2012) Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: a structured review. Surg Infect (Larchmt) 13:9-17
-
(2012)
Surg Infect (Larchmt)
, vol.13
, pp. 9-17
-
-
Adnan, S.1
Paterson, D.L.2
Lipman, J.3
Kumar, S.4
Li, J.5
Rudd, M.6
Roberts, J.A.7
-
32
-
-
77954078062
-
Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock
-
Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Wittebole X, De Backer D, Layeux B, Vincent JL, Wallemacq P, Jacobs F (2010) Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care 14:R126
-
(2010)
Crit Care
, vol.14
-
-
Taccone, F.S.1
Laterre, P.F.2
Dugernier, T.3
Spapen, H.4
Delattre, I.5
Wittebole, X.6
De Backer, D.7
Layeux, B.8
Vincent, J.L.9
Wallemacq, P.10
Jacobs, F.11
-
33
-
-
84886656109
-
Dose modulation: A new concept of antibiotic therapy in the critically ill patient?
-
Goncalves-Pereira J, Paiva JA (2013) Dose modulation: a new concept of antibiotic therapy in the critically ill patient? J Crit Care 28:341-346
-
(2013)
J Crit Care
, vol.28
, pp. 341-346
-
-
Goncalves-Pereira, J.1
Paiva, J.A.2
-
34
-
-
0029557649
-
Changes in vancomycin pharmacokinetics in critically ill infants
-
Gous AG, Dance MD, Lipman J, Luyt DK, Mathivha R, Scribante J (1995) Changes in vancomycin pharmacokinetics in critically ill infants. Anaesth Intensive Care 23:678-682 (Pubitemid 26015336)
-
(1995)
Anaesthesia and Intensive Care
, vol.23
, Issue.6
, pp. 678-682
-
-
Gous, A.G.S.1
Dance, M.D.2
Lipman, J.3
Luyt, D.K.4
Mathivha, R.5
Scribante, J.6
-
35
-
-
84899440064
-
Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: A randomised controlled trial
-
De Waele JJ, Carrette S, Carlier M, Stove V, Boelens J, Claeys G, Leroux-Roels I, Hoste E, Depuydt P, Decruyenaere J, Verstraete AG (2014) Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial. Intensive Care Med 40:380-387
-
(2014)
Intensive Care Med
, vol.40
, pp. 380-387
-
-
De Waele, J.J.1
Carrette, S.2
Carlier, M.3
Stove, V.4
Boelens, J.5
Claeys, G.6
Leroux-Roels, I.7
Hoste, E.8
Depuydt, P.9
Decruyenaere, J.10
Verstraete, A.G.11
-
36
-
-
77954849218
-
Therapeutic drug monitoring of beta-lactams in critically ill patients: Proof of concept
-
Roberts JA, Ulldemolins M, Roberts MS, McWhinney B, Ungerer J, Paterson DL, Lipman J (2010) Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. Int J Antimicrob Agents 36:332-339
-
(2010)
Int J Antimicrob Agents
, vol.36
, pp. 332-339
-
-
Roberts, J.A.1
Ulldemolins, M.2
Roberts, M.S.3
McWhinney, B.4
Ungerer, J.5
Paterson, D.L.6
Lipman, J.7
-
37
-
-
0036225961
-
Can PK/PD be used in everyday clinical practice
-
Scaglione F (2002) Can PK/PD be used in everyday clinical practice. Int J Antimicrob Agents 19:349-353
-
(2002)
Int J Antimicrob Agents
, vol.19
, pp. 349-353
-
-
Scaglione, F.1
-
38
-
-
77949658167
-
Daily serum piperacillin monitoring is advisable in critically ill patients
-
Blondiaux N, Wallet F, Favory R, Onimus T, Nseir S, Courcol RJ, Durocher A, Roussel-Delvallez M (2010) Daily serum piperacillin monitoring is advisable in critically ill patients. Int J Antimicrob Agents 35:500-503
-
(2010)
Int J Antimicrob Agents
, vol.35
, pp. 500-503
-
-
Blondiaux, N.1
Wallet, F.2
Favory, R.3
Onimus, T.4
Nseir, S.5
Courcol, R.J.6
Durocher, A.7
Roussel-Delvallez, M.8
-
39
-
-
78751700543
-
Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis
-
Connor MJJ, Salem C, Bauer SR, Hofmann CL, Groszek J, Butler R, Rehm SJ, Fissell WH (2011) Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis. Antimicrob Agents Chemother 55:557-560
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 557-560
-
-
Connor, M.J.J.1
Salem, C.2
Bauer, S.R.3
Hofmann, C.L.4
Groszek, J.5
Butler, R.6
Rehm, S.J.7
Fissell, W.H.8
|